[On the use of low molecular polyvinylpyrrolidone in the combined treatment of hemolytic disease in newborn infants].
D003131:Combined Modality Therapy; D004899:Erythroblastosis, Fetal; D005333:Fetus; D006402:Hematologic Diseases; D011205:Povidone
D011205:Povidone
ERYTHROBLASTOSIS, FETAL; POLYVINYLPYRROLIDONE